Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
GRAYZEL DAVID S.
Director at Jade Biosciences. Filing since 2 Jul 2021.
CIK 0001732786
Company
Date
Role
Action
Shares
Amount
Of holding
JBIO
Jade Biosciences, Inc.
9 Apr 2024
Director
Sold at will
11,882
$334.48K
45.0%
JBIO
Jade Biosciences, Inc.
2 Jul 2021
Director
Bought
535,714
$7.50M
20.9%
2 decisions on file.
